Hazlett, Burt & Watson
FBT icon

Hazlett, Burt & Watson’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Hazlett, Burt & Watson’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$54K Hold
201
– – 0.01% 449
2026
Q2 		$50K Hold
201
– – 0.01% 465
2026
Q1 		$40K Hold
201
– – 0.01% 483
2025
Q4 		$42K Hold
201
– – 0.01% 468
2025
Q3 		$36K Buy
201
+101
+101% +$17.2K 0.01% 470
2025
Q2 		$16K Buy
+100
New +$15.9K 0.01% 529

Other funds holding FBT

LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Nilsine Partners
Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return
D.A. Davidson & Co
D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return
Bensler
Bensler Bellevue, Washington $1.06B AUM 29.38% 1-Year Est. Return
Csenge Advisory Group
Csenge Advisory Group Clearwater, Florida $2.53B AUM 18.15% 1-Year Est. Return
NewSquare Capital
NewSquare Capital Newtown Square, Pennsylvania $1.38B AUM 24% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Kestra Advisory Services
Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Hazlett, Burt & Watson's FBT Position: Q3 2026 in Review

Hazlett, Burt & Watson held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2026 at 201 shares worth $54K. The position accounts for 0.01% of the portfolio, ranked #449.

Hazlett, Burt & Watson first reported a position in FBT in Q2 2025 and has held it in 6 quarters since. 219 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Hazlett, Burt & Watson held 201 shares of First Trust NYSE Arca Biotechnology Index Fund worth $54K as of Q3 2026.
  • Hazlett, Burt & Watson left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #449 holding.
  • Hazlett, Burt & Watson first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2025 and has held it in 6 quarters since.
  • 219 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.